Interindividual variability in sensitivity to warfarin--Nature or nurture?
about
Warfarin reversalInfluence of CYP2C9 and VKORC1 on patient response to warfarin: a systematic review and meta-analysisWarfarin Pharmacogenetics: New Life for an Old DrugA prospective, randomized pilot trial of model-based warfarin dose initiation using CYP2C9 genotype and clinical dataClinical and genetic determinants of warfarin pharmacokinetics and pharmacodynamics during treatment initiation10 years of oral anticoagulant pharmacogenomics: what difference will it make? A critical appraisal.Pharmacogenetics of warfarin: challenges and opportunities.Comparison of warfarin therapy clinical outcomes following implementation of an automated mobile phone-based critical laboratory value text alert systemWarfarin and vitamin K intake in the era of pharmacogenetics.Genotype-based dosing algorithms for warfarin therapy: data review and recommendations.Pharmacogenomics: a systems approach.Pharmacogenetics of anticoagulants.Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Warfarin sensitivity related to CYP2C9, CYP3A5, ABCB1 (MDR1) and other factors.Genotyping three SNPs affecting warfarin drug response by isothermal real-time HDA assays.CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients: a HuGEnet systematic review and meta-analysis.Common VKORC1 and GGCX polymorphisms associated with warfarin dose.A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity.Genotype and risk of major bleeding during warfarin treatment.Genetic warfarin dosing: tables versus algorithms.Pharmacogenetics in drug regulation: promise, potential and pitfalls.Fenofibrate potentiates warfarin effects.The impact of VKORC1-1639 G>A polymorphism on the maintenance dose of oral anticoagulants for thromboembolic prophylaxis in North India: A pilot studyPharmacogenetics of CYP2C9 and interindividual variability in anticoagulant response to warfarin.Influence of genetic, biological and pharmacological factors on warfarin dose in a Southern Brazilian population of European ancestry.Clinical relevance of genetic polymorphisms in the human CYP2C9 gene.Association of warfarin dose with genes involved in its action and metabolism.The population pharmacokinetics of R- and S-warfarin: effect of genetic and clinical factors.Genetic polymorphisms of cytochrome P450 enzymes and the effect on interindividual, pharmacokinetic variability in extensive metabolizers.Drug development and use in the elderly: search for the right dose and dosing regimen (Parts I and II).Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate-intensity anticoagulation?Effects of lasofoxifene on the pharmacokinetics and pharmacodynamics of single-dose warfarin.Toward individualized pharmaceutical care of East Asians: the value of genetic testing for polymorphisms in drug-metabolizing genes.Differences in drug pharmacokinetics between East Asians and Caucasians and the role of genetic polymorphisms.Genetic and environmental factors determining clinical outcomes and cost of warfarin therapy: a prospective study.Mechanistic basis of adverse drug reactions: the perils of inappropriate dose schedules.Prediction of warfarin dose reductions in Puerto Rican patients, based on combinatorial CYP2C9 and VKORC1 genotypes.The pharmacogenetics of coumarin therapy.Influence of adult age on the total and free clearance and protein binding of (R)- and (S)-warfarinA multi-factorial analysis of response to warfarin in a UK prospective cohort
P2860
Q24672566-D1C07420-299E-4B06-A5C2-68827170A774Q27002899-735AB391-060C-4910-88A2-550637031ADFQ28468726-6552358E-DEB7-42EA-AEEE-8133846481A2Q31004538-9532B216-124E-4632-ABC6-E503985E32A2Q31042226-29717229-9873-463E-945E-52000443E768Q33517162-63136DAA-0AF1-4D95-B237-6F0F207A415EQ33819050-BCC685E6-D9B5-47B9-BCE3-C3671843D15AQ33912263-76695861-DBFE-4CB3-B994-A413B70897BBQ34026225-8284F423-393B-4F2F-A7FD-7007E87C5847Q34065133-C41FD9C7-4D99-4C2A-B5AE-D58DDFBDFF38Q34137575-6132E6B6-CADB-4273-B472-0F12F8279E34Q34219746-69032AAB-12ED-4DF5-837C-7D173F93966CQ34252907-726A7E38-7CD2-49CF-B0A7-5FC4A591A939Q34283903-FA7A5777-5D5A-4EEA-B889-48C0640E5D5DQ34348637-F1391F50-915F-42BA-A88C-D0A87BF907F2Q34394876-6DF6CF7B-E914-492A-B74D-642EC6CAE933Q34417386-4FC999BE-483B-4DA9-B65F-9BCCEF713C86Q34418092-4EF6EB45-85A5-40A9-BA3B-AACDDA1550F0Q35006973-F478BA30-829D-45C8-8598-F176CE98274EQ35021027-53C78397-1BB8-4502-9FC6-F4F8BA1816FAQ35038052-90DCF26C-9E17-4A99-80AC-8E8CEF811CF2Q35054251-0EB3A389-6A61-4EC8-945B-A25BD9B1F6EBQ35073505-37B7D015-CA99-4FED-BBA0-B0CCA11F0B40Q35204081-D97E2AFB-0C6D-4DB0-B7F8-84B9C8FD12BDQ35219654-173A556F-D0FB-44AA-9F68-CA5B7CE5CDB8Q35594567-A285CBB1-8079-4595-897D-99B2F230FBAEQ35633802-7FF82FC8-BE00-4D02-95A6-D63415971124Q35640455-7CFDCEF7-4A94-422B-8079-F41C94F432DAQ35753607-891CE161-7831-4AF6-B8EE-958853FE25CCQ35826495-8FD47EE7-F745-4C99-A7B3-5E4F66C72662Q35826999-29C2AF99-4650-412E-A175-2878FC02B65BQ35827687-7BD46358-557A-41D5-8CCF-A57FC9A8F7A9Q35873687-3AB3F82C-71CF-4291-81DB-4E5365C9ED9DQ35876954-0CF566F7-1DC7-4245-AEF6-B0956E30E17FQ35900767-C31C72D4-C32C-40FD-BB9F-A41D5C8C9977Q36040772-26FD4CBB-C552-4DDE-A02E-E9AEEB32BA30Q36044022-F2F2317B-B3EA-41BA-B665-9AE88F24FFBCQ36192806-5008772C-F2EF-4882-B564-376B456E364EQ36390244-BAA7402C-41A6-4BC3-9A25-99F523B35263Q36433323-A228CA86-CCBC-4D3F-BBB6-F18517185D8D
P2860
Interindividual variability in sensitivity to warfarin--Nature or nurture?
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Interindividual variability in sensitivity to warfarin--Nature or nurture?
@en
Interindividual variability in sensitivity to warfarin--Nature or nurture?
@nl
type
label
Interindividual variability in sensitivity to warfarin--Nature or nurture?
@en
Interindividual variability in sensitivity to warfarin--Nature or nurture?
@nl
prefLabel
Interindividual variability in sensitivity to warfarin--Nature or nurture?
@en
Interindividual variability in sensitivity to warfarin--Nature or nurture?
@nl
P2093
P356
P1476
Interindividual variability in sensitivity to warfarin--Nature or nurture?
@en
P2093
Loebstein R
Lubetsky A
Roitelman J
Rotenberg M
P304
P356
10.1067/MCP.2001.117444
P407
P577
2001-08-01T00:00:00Z